Skip to main content
. 2021 Aug 17;11:16663. doi: 10.1038/s41598-021-96089-x

Figure 5.

Figure 5

Progression-free and overall survival of NAFLD/NASH and Viral/Alcohol groups. (a) Progression-free survival. Viral/Alcohol (median 7.5 months, 95% CI 6.8–8.0), NAFLD/NASH (median 9.3 months, 95% CI 7.8–13.5) (P = 0.012). (b) Overall survival. Viral/Alcohol (median 16.9 months, 95% CI 14.5–18.6), NAFLD/NASH (median 20.5 months, 95% CI 16.8–29.5). (P = 0.057).